An Open-Label, Safety Study for Previously Treated

  • Karachunski, Peter I (PI)
  • Day, John W (Prior Principal Investigator)
  • Raymond, Gerald V (Prior Principal Investigator)

Project: Research project

Project Details

Description

An Open-Label, Safety Study for Previously Treated Ataluren (PTC124) Patients with Nonsense Mutation Dystrophinopathy
StatusActive
Effective start/end date11/1/102/27/21

Funding

  • PTC Therapeutics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.